Life ScienceCompany
Who owns Gemini Bio?
Gemini Bio is owned by BelHealth Investment Partners and The BroadOak Fund. It was acquired in 2018.
Gemini Bio is owned by BelHealth Investment Partners and The BroadOak Fund. It was acquired in 2018.
930 Riverside Parkway,
West Sacramento, California
95605
United States,
(800) 543-6464
www.geminibio.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2018-09-14 | BelHealth Investment Partners, The BroadOak Fund | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
